Deficiency of the macrophage migration inhibitory factor gene has no significant effect on endotoxaemia

被引:63
作者
Honma, N
Koseki, H
Akasaka, T
Nakayama, T
Taniguchi, M
Serizawa, I
Akahori, H
Osawa, M
Mikayama, T
机构
[1] Kirin Brewery Co Ltd, Pharmaceut Res Lab, Gunma, Japan
[2] Chiba Univ, Grad Sch Med, Dept Mol Immunol, Chiba, Japan
[3] Chiba Univ, Grad Sch Med, Dept Mol Embryol, Chiba, Japan
关键词
D O I
10.1046/j.1365-2567.2000.00011.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
By targeted disruption of the MIF gene, we have established a mouse strain deficient in macrophage (M phi) migration inhibitory factor (MIF). Despite previous reports indicating an essential role of MIF in endotoxaemia, an injection of lipopolysaccharide (LPS) into the MIF-deficient mice (maintained under specific pathogen-free conditions) caused shock. No significant difference was detected between the MIF-deficient mutant and normal mice in susceptibility to LPS for endotoxaemia or tumour necrosis factor-alpha (TNF-alpha) formation upon LPS injection. Peritoneal M phi from the two strains produced TNF-alpha in response to LPS with similar dose responses. Dexamethasone suppressed the LPS-induced TNF-alpha response of M phi, but no difference was detected between the M phi from the two strains. These results suggest that endogenous MIF has no significant effect on the LPS-induced TNF-alpha production and no effect on suppression of the response by glucocorticoids. Thus, MIF is not crucial for LPS-induced immune responses leading to shock.
引用
收藏
页码:84 / 90
页数:7
相关论文
共 44 条
[1]
Lipopolysaccharide-induced cytokine cascade and lethality in LTα/TNFα-deficient mice [J].
Amiot, F ;
Fitting, C ;
Tracey, KJ ;
Cavaillon, JM ;
Dautry, F .
MOLECULAR MEDICINE, 1997, 3 (12) :864-875
[2]
Apte RS, 1998, J IMMUNOL, V160, P5693
[3]
Balkhy HH, 1999, J IMMUNOL, V162, P3633
[4]
MIF IS A PITUITARY-DERIVED CYTOKINE THAT POTENTIATES LETHAL ENDOTOXEMIA [J].
BERNHAGEN, J ;
CALANDRA, T ;
MITCHELL, RA ;
MARTIN, SB ;
TRACEY, KJ ;
VOELTER, W ;
MANOGUE, KR ;
CERAMI, A ;
BUCALA, R .
NATURE, 1993, 365 (6448) :756-759
[5]
PURIFICATION, BIOACTIVITY, AND SECONDARY STRUCTURE-ANALYSIS OF MOUSE AND HUMAN MACROPHAGE-MIGRATION INHIBITORY FACTOR (MIF) [J].
BERNHAGEN, J ;
MITCHELL, RA ;
CALANDRA, T ;
VOELTER, W ;
CERAMI, A ;
BUCALA, R .
BIOCHEMISTRY, 1994, 33 (47) :14144-14155
[6]
The emerging role of MIF in septic shock and infection [J].
Bernhagen, J ;
Calandra, T ;
Bucala, R .
BIOTHERAPY, 1995, 8 (02) :123-127
[7]
Bernhagen Juergen, 1994, Trends in Microbiology, V2, P198, DOI 10.1016/0966-842X(94)90111-H
[8]
PASSIVE-IMMUNIZATION AGAINST CACHECTIN TUMOR NECROSIS FACTOR PROTECTS MICE FROM LETHAL EFFECT OF ENDOTOXIN [J].
BEUTLER, B ;
MILSARK, IW ;
CERAMI, AC .
SCIENCE, 1985, 229 (4716) :869-871
[9]
MECHANISM OF A REACTION IN VITRO ASSOCIATED WITH DELAYED-TYPE HYPERSENSITIVITY [J].
BLOOM, BR ;
BENNETT, B .
SCIENCE, 1966, 153 (3731) :80-&
[10]
STRUCTURAL CHARACTERIZATION AND CHROMOSOMAL LOCATION OF THE MOUSE MACROPHAGE-MIGRATION INHIBITORY FACTOR GENE AND PSEUDOGENES [J].
BOZZA, M ;
KOLAKOWSKI, LF ;
JENKINS, NA ;
GILBERT, DJ ;
COPELAND, NG ;
DAVID, JR ;
GERARD, C .
GENOMICS, 1995, 27 (03) :412-419